Gerald M McInerney Selected Research

Infections

1/2020	Replication of Salmonella enterica serovar Typhimurium in RAW264.7 Phagocytes Correlates With Hypoxia and Lack of iNOS Expression.
10/2019	RNA processing bodies are disassembled during Old World alphavirus infection.
1/2018	Mutation of CD2AP and SH3KBP1 Binding Motif in Alphavirus nsP3 Hypervariable Domain Results in Attenuated Virus.
12/2017	A Link Between a Common Mutation in CFTR and Impaired Innate and Adaptive Viral Defense.
11/2016	The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
5/2015	Protection of human myeloid dendritic cell subsets against influenza A virus infection is differentially regulated upon TLR stimulation.
8/2013	Influenza A virus-mediated priming enhances cytokine secretion by human dendritic cells infected with Streptococcus pneumoniae.
5/2012	Accumulation of autophagosomes in Semliki Forest virus-infected cells is dependent on expression of the viral glycoproteins.
1/2009	Direct cleavage, proteasomal degradation and sequestration: three mechanisms of viral subversion of type I interferon responses.
8/2005	Importance of eIF2alpha phosphorylation and stress granule assembly in alphavirus translation regulation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gerald M McInerney Research Topics

Disease

11	Infections 01/2020 - 08/2005
6	Virus Diseases (Viral Diseases) 01/2022 - 08/2005
3	Alphavirus Infections 11/2016 - 08/2005
2	Communicable Diseases (Infectious Diseases) 01/2020 - 01/2017
1	COVID-19 11/2020
1	Salmonella Infections (Salmonellosis) 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Melanoma (Melanoma, Malignant) 01/2018
1	Ross River Virus Infection 01/2018
1	Inflammation (Inflammations) 05/2015
1	Bites and Stings (Sting) 12/2014
1	Coinfection 08/2013
1	Starvation 05/2012

Drug/Important Bio-Agent (IBA)

7	Antiviral Agents (Antivirals)IBA 01/2022 - 08/2005
6	Proteins (Proteins, Gene)FDA Link 01/2020 - 08/2005
3	RNA (Ribonucleic Acid)IBA 10/2019 - 12/2014
2	Viral ProteinsIBA 11/2015 - 08/2005
2	ras GTPase-Activating Proteins (ras-GAP)IBA 02/2015 - 12/2012
2	Interferon Type IIBA 08/2013 - 01/2009
1	Single-Domain AntibodiesIBA 01/2022
1	AntibodiesIBA 01/2022
1	Neutralizing AntibodiesIBA 11/2020
1	VaccinesIBA 01/2020
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	Uridine Triphosphate (UTP)IBA 10/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2018
1	Chloroquine (Aralen)FDA LinkGeneric 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	AminesIBA 01/2018
1	ElementsIBA 01/2018
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 12/2017
1	FurinIBA 01/2017
1	Mitogen-Activated Protein KinasesIBA 11/2016
1	BerberineIBA 11/2016
1	Pharmaceutical PreparationsIBA 11/2016
1	Phosphotransferases (Kinase)IBA 11/2016
1	LigandsIBA 05/2015
1	Carrier Proteins (Binding Protein)IBA 02/2015
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 12/2014
1	Immunoglobulin M (IgM)IBA 12/2014
1	Interleukin-6 (Interleukin 6)IBA 08/2013
1	CytokinesIBA 08/2013
1	Messenger RNA (mRNA)IBA 12/2012
1	Viral RNAIBA 12/2012
1	Viral Nonstructural ProteinsIBA 12/2012
1	Amino Acids FDA Link 05/2012
1	TOR Serine-Threonine KinasesIBA 05/2012
1	Peptide Initiation Factors (Initiation Factor)IBA 08/2005

Therapy/Procedure

1	Therapeutics 01/2022